Front Row Advisors LLC Hologic Inc Transaction History

Front Row Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$71.43 - $78.41 $1,071 - $1,176	-15 Reduced 7.58%	183 $13,000
Q1 2024 May 14, 2024	BUY	$71.33 - $77.96 $14,123 - $15,436	198 New	198 $15,000
Q3 2023 Nov 15, 2023	BUY	$69.24 - $81.9 $1,177 - $1,392	17 Added 13.18%	146 $10,000
Q2 2023 Aug 14, 2023	BUY	$77.76 - $87.67 $233 - $263	3 Added 2.38%	129 $10,000
Q1 2023 May 22, 2023	BUY	$75.55 - $86.16 $8,763 - $9,994	116 Added 1160.0%	126 $10,000
Q1 2023 May 15, 2023	SELL	$75.55 - $86.16 $8,763 - $9,994	-116 Reduced 92.06%	10 $13,000
Q3 2022 Nov 15, 2022	SELL	$62.71 - $73.47 $125 - $146	-2 Reduced 1.56%	126 $8,000
Q2 2022 Aug 15, 2022	BUY	$67.12 - $79.99 $469 - $559	7 Added 5.79%	128 $9,000
Q1 2022 May 11, 2022	BUY	$68.08 - $76.82 $3,676 - $4,148	54 Added 80.6%	121 $9,000
Q4 2020 Feb 25, 2021	SELL	$65.85 - $76.67 $921 - $1,073	-14 Reduced 17.28%	67 $5,000
Q1 2020 May 08, 2020	BUY	$29.38 - $54.65 $1,351 - $2,513	46 Added 131.43%	81 $4,000
Q3 2019 Nov 08, 2019	SELL	$47.08 - $51.5 $2,165 - $2,369	-46 Reduced 56.79%	35 $2,000
Q4 2017 Feb 01, 2018	BUY	$35.9 - $43.82 $2,907 - $3,549	81	81 $3,000

777

220M

874K

371K

Ticker HOLX
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 249,652,992
Market Cap $18.2B
Description
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.